title: Haematological recovery in dyskeratosis congenita patients treated with danazol.
authors.forename: Amin
authors.initials: A
authors.lastname: Islam
authors.forename: Shafquat
authors.initials: S
authors.lastname: Rafiq
authors.forename: Mike
authors.initials: M
authors.lastname: Kirwan
authors.forename: Amanda
authors.initials: A
authors.lastname: Walne
authors.forename: Jamie
authors.initials: J
authors.lastname: Cavenagh
authors.forename: Tom
authors.initials: T
authors.lastname: Vulliamy
authors.forename: Inderjeet
authors.initials: I
authors.lastname: Dokal
mesh_terms: D000328:Adult; D003613:Danazol / Q000627:therapeutic use*; D019871:Dyskeratosis Congenita / Q000097:blood* / Q000188:drug therapy* / Q000235:genetics; D005260:Female; D006801:Humans
chemical_list: D003613:Danazol
keywords: bone marrow failure; danazol; dyskeratosis congenita; telomerase; telomeres